Fig. 3From: Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitisInflammatory CSF cytokine levels, bacterial titers and cerebral complications during acute pneumococcal meningitis. Six hours after treatment initiation, adjuvant metformin significantly reduced levels of IL-1β (p = 0.015 and p = 0.034 at 24 h after treatment initiation, a), IL-6 (p = 0.036, b), and TNF-α (p = 0.044, d) and showed a trend toward reduced IL-10 levels (p = 0.059, c), despite having comparable CSF cytokine levels and bacterial titers at time of therapy initiation (a–e). Adjuvant metformin significantly reduced levels of cortical necrosis at 42 h post infection (p = 0.0101, f)Back to article page